Approval · Notice of Compliance 20903 · 2018
MAR-FLECAINIDE: Notice of Compliance 20903
Issued May 28, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20903
- Date
- May 28, 2018
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- FLECAINIDE (AA Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MAR-FLECAINIDE | 02476177 | Dormant |
| MAR-FLECAINIDE | 02476185 | Dormant |
Medicinal ingredients
- FLECAINIDE ACETATE 50 MG per TAB
- FLECAINIDE ACETATE 100 MG per TAB